New dissolving pill aims to protect kidneys in liver transplant patients
Disease control
Not yet recruiting
This study looks at whether switching to a new, easy-to-take dissolving form of the hepatitis B drug entecavir is safe and helps protect kidney function in adults who have had a liver transplant. About 82 stable patients who have been on standard entecavir for at least a year wil…
Phase: PHASE2 • Sponsor: Jongman Kim • Aim: Disease control
Last updated May 17, 2026 08:00 UTC